U.S. Physical Therapy, Inc. (NYSE:USPH) Position Trimmed by MQS Management LLC

MQS Management LLC lowered its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 19.6% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,678 shares of the company’s stock after selling 1,138 shares during the period. MQS Management LLC’s holdings in U.S. Physical Therapy were worth $396,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. BNP Paribas Financial Markets grew its stake in U.S. Physical Therapy by 6.8% during the 1st quarter. BNP Paribas Financial Markets now owns 7,837 shares of the company’s stock worth $885,000 after buying an additional 502 shares during the last quarter. Texas Permanent School Fund Corp increased its holdings in shares of U.S. Physical Therapy by 1.3% in the 1st quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock worth $1,480,000 after acquiring an additional 170 shares during the period. Envestnet Portfolio Solutions Inc. bought a new stake in U.S. Physical Therapy in the 1st quarter valued at about $391,000. SG Americas Securities LLC acquired a new position in U.S. Physical Therapy during the 1st quarter valued at about $485,000. Finally, Sei Investments Co. grew its position in U.S. Physical Therapy by 5.3% in the 1st quarter. Sei Investments Co. now owns 79,321 shares of the company’s stock worth $8,953,000 after purchasing an additional 3,982 shares during the last quarter.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $82.50, for a total transaction of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at approximately $580,635. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kathleen A. Gilmartin purchased 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, September 3rd. The shares were purchased at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now owns 18,904 shares in the company, valued at $1,627,445.36. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 8,620 shares of company stock valued at $799,170 over the last quarter. Company insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Stock Down 0.2 %

Shares of USPH stock opened at $91.87 on Thursday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.88 and a current ratio of 1.78. The stock has a market cap of $1.39 billion, a PE ratio of 97.73, a price-to-earnings-growth ratio of 4.16 and a beta of 1.38. The business’s fifty day moving average is $84.02 and its 200-day moving average is $91.26. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. During the same quarter last year, the business posted $0.76 EPS. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. Equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 1.92%. U.S. Physical Therapy’s payout ratio is currently 187.23%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on USPH shares. Bank of America reiterated a “neutral” rating and set a $90.00 price objective (down from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Finally, Barrington Research restated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 7th.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.